Canada Life’s Neurogene NGNE Stock Holding History

Canada Life’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-140	Closed	-$20K	–	2536
2021 Q3	$20K	Hold	140	–	–	﹤0.01%	2441
2021 Q2	$26K	Hold	140	–	–	﹤0.01%	2435
2021 Q1	$34K	Hold	140	–	–	﹤0.01%	2413
2020 Q4	$39K	Hold	140	–	–	﹤0.01%	2367
2020 Q3	$34K	Hold	140	–	–	﹤0.01%	2288
2020 Q2	$46K	Buy	+140	New	+$36.5K	﹤0.01%	2239

Other funds holding NGNE

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Canada Life's NGNE Position: Q4 2021 in Review

Canada Life sold out of Neurogene (NGNE) in Q4 2021, closing a stake of 140 shares — an estimated $20K sold.

Canada Life first reported a position in NGNE in Q2 2020 and held it in 6 quarters. The position peaked at $46K in Q2 2020. 80 funds tracked by Wall St. Rank hold NGNE as of Q4 2021.

Canada Life reported no remaining Neurogene position as of Q4 2021 after selling out during the quarter.
Canada Life sold 140 Neurogene shares in Q4 2021, an estimated $20K.
Canada Life first reported a position in Neurogene in Q2 2020 and held it in 6 quarters.
Canada Life's Neurogene position peaked at $46K in Q2 2020.
80 funds tracked by Wall St. Rank held Neurogene as of Q4 2021.

Based on Canada Life's 13F filing for Q4 2021, filed 14 Feb 2022.